UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extremely High Mutation Rate of HIV-1 In Vivo

PLoS biology, 2015-09, Vol.13 (9), p.e1002251-e1002251

2015

Volltextzugriff (PDF)

Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in Spain

Clinical infectious diseases, 2013-01, Vol.56 (1), p.143-150

2013

Volltextzugriff (PDF)

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis

Journal of acquired immune deficiency syndromes (1999), 2009-06, Vol.51 (2), p.147-152

2009

Volltextzugriff (PDF)

HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma

AIDS (London), 2014-01, Vol.28 (1), p.41-47

2014

Volltextzugriff (PDF)

Sustained Virological Response to Interferon Plus Ribavirin Reduces Non—Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus

Clinical infectious diseases, 2012-09, Vol.55 (5), p.728-736

2012

Volltextzugriff (PDF)

Osteonecrosis in patients infected with HIV: clinical epidemiology and natural history in a large case series from Spain

Journal of acquired immune deficiency syndromes (1999), 2006-07, Vol.42 (3), p.286-292

2006

Volltextzugriff (PDF)

Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus

Clinical infectious diseases, 2015-03, Vol.60 (6), p.950-958

2015

Volltextzugriff (PDF)

Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy

Antiviral therapy, 2012-01, Vol.17 (3), p.577-583

2012

Volltextzugriff (PDF)

The effects of Maraviroc on liver fibrosis in HIV/HCV co‐infected patients

Journal of the International AIDS Society, 2014-11, Vol.17 (4 Suppl 3), p.19643-n/a

2014

Volltextzugriff (PDF)

Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy

AIDS reviews, 2012-04, Vol.14 (2), p.112-123

2012

Volltextzugriff (PDF)

Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus

Journal of hepatology, 2013-06, Vol.58 (6), p.1104-1112

2013

Volltextzugriff (PDF)

Short―term and long―term clinical and immunological consequences of stopping antiretroviral therapy in HIV―infected patients with preserved immune function

Antiviral therapy, 2013, Vol.18 (1), p.125-130

2013

Volltextzugriff (PDF)

Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

Journal of antimicrobial chemotherapy, 2011-12, Vol.66 (12), p.2843-2849

2011

Volltextzugriff (PDF)

Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results

Enfermedades infecciosas y microbiología clínica, 2007-01, Vol.25 (1), p.23

2007

Volltextzugriff (PDF)

Cardiovascular risk in human immunodeficiency virus-infected patients in Spain. CoRIS cohort, 2011

Enfermedades infecciosas y microbiologia clinica, 2012-11, Vol.30 (9), p.517

2012

Volltextzugriff (PDF)

The future of antiretroviral therapy: challenges and needs

Journal of antimicrobial chemotherapy, 2010-05, Vol.65 (5), p.827-835

2010

Volltextzugriff (PDF)

Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016

Enfermedades infecciosas y microbiologia clinica (English ed.), 2017-06, Vol.35 (6), p.377-383

2017

Volltextzugriff (PDF)

Co-ocurrence of myasthenia gravis with Parkinson's disease: A not to be missed diagnosis

Geriatrics & gerontology international, 2016-04, Vol.16 (4), p.528-530

2016

Volltextzugriff (PDF)

Clinical Utility of Maraviroc

Clinical drug investigation, 2011-01, Vol.31 (8), p.527-542

2011

Volltextzugriff (PDF)

Sustained virological response to interferon plus ribavirin reduces liver‐related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus

Hepatology (Baltimore, Md.), 2009-08, Vol.50 (2), p.407-413

2009

Volltextzugriff (PDF)

Consensus document on the management of renal disease in HIV-infected patients

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2014, Vol.34 Suppl 2, p.1

2014

Volltextzugriff (PDF)

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection

Enfermedades infecciosas y microbiologia clinica, 2015-01, Vol.33 (1), p.41-47

2015

Volltextzugriff (PDF)

Evolution of HIV-1 Genotype in Plasma RNA and Peripheral Blood Mononuclear Cells Proviral Dna after Interruption and Resumption of Antiretroviral Therapy

Antiviral therapy, 2012-04, Vol.17 (3), p.597-597

2012

Volltextzugriff (PDF)

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort

Journal of antimicrobial chemotherapy, 2009-01, Vol.63 (1), p.189-196

2009

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Aktive Filter

ThemaSida

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Englisch
(77)
Spanisch
(44)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Extremely High Mutation Rate of HIV-1 In Vivo

Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in Spain

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis

HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma

Sustained Virological Response to Interferon Plus Ribavirin Reduces Non—Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus

Osteonecrosis in patients infected with HIV: clinical epidemiology and natural history in a large case series from Spain

Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus

Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy

The effects of Maraviroc on liver fibrosis in HIV/HCV co‐infected patients

Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy

Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus

Short―term and long―term clinical and immunological consequences of stopping antiretroviral therapy in HIV―infected patients with preserved immune function

Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results

Cardiovascular risk in human immunodeficiency virus-infected patients in Spain. CoRIS cohort, 2011

The future of antiretroviral therapy: challenges and needs

Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016

Co-ocurrence of myasthenia gravis with Parkinson's disease: A not to be missed diagnosis

Clinical Utility of Maraviroc

Sustained virological response to interferon plus ribavirin reduces liver‐related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus

Consensus document on the management of renal disease in HIV-infected patients

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection

Evolution of HIV-1 Genotype in Plasma RNA and Peripheral Blood Mononuclear Cells Proviral Dna after Interruption and Resumption of Antiretroviral Therapy

Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort

Aktive Filter

Suchergebnisse filtern